glp 1 thyroid Glucagon-like peptide receptor agonist use and risk of cancer: Scandinavian cohort study After my post yesterday, I

Switching requires medical supervision

The INVEST Study at a Glance The INVEST study examined body composition changes in individuals during dietary weight loss

Advantage: Eli Lilly has the advantage of possessing a next-generation drug (tirzepatide) that has demonstrated impressive results, particularly in the obesity space

Many people expect nausea on GLP-1 medications

Those are big ranges in protein, fiber & calories..odd they don't list carbs it's also odd (& incorrect) that they have called these Ozempic smoothies since Ozempic is the dose of semaglutide for T2 diabetes & WEGOVY is the dosage for obesity management

However, most studies of pancreatic mass or exocrine cellular proliferation have reported no change with exenatide, liraglutide, or dulaglutide (86, 108, 109, 119, 121)